ANTIBODIES

Contributor Information
- Name Sharon Tooze
- Institute Cancer Research UK, London Research Institute: Lincoln's Inn Fields
Tool Details
- Tool name: Anti-WIPI2 [2A2]
- Clone: 2A2
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human ; Mouse
- Host: Mouse
- Molecular weight of the target: 49 kDa
- Application: IF ; FACS ; IF ; IP ; WB
- Description: This antibody is useful for the detection of WIPI-2, an essential protein for autophagy.
- Immunogen: Synthetic peptide corresponding to C-terminus of WIPI2b CSALRLDEDSEHPPMILRTD
- Isotype: IgG1 kappa
- Research area: Cancer; Tissue-specific biology; Biochemistry
- For Research Use Only
Target Details
- Target: WIPI2
- Target molecular weight: 49 kDa
- Target background: WIPI2 is a mammalian effector of PtdIns3P and is ubiquitously expressed in a variety of cell lines. WIPI2 is recruited to early autophagosomal structures along with Atg16L and ULK1 and is required for the formation of LC3-positive autophagosomes. WIPI-2 is the mammalian homologue of Atg18.
Application Details
- Application: IF ; FACS ; IF ; IP ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15ðC to -25ðC
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Nishimura et al. 2017. EMBO J. 36(12):1719-1735. PMID: 28495679.
- • Autophagosome formation is initiated at phosphatidylinositol synthase-enriched ER subdomains.
- • Martinez-Martin et al. 2017. Science. 355(6325):641-647. PMID: 28183981.
- • A switch from canonical to noncanonical autophagy shapes B cell responses.
- • Polson et al. 2010. Autophagy. 6(4):506-22. PMID: 20505359.
- • Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation.
- • Li et al. 2005. J Biol Chem. 280(29):26941-52. PMID: 15917248.
- • Kr
ppel-like factor-6 promotes preadipocyte differentiation through histone deacetylase 3-dependent repression of DLK1. - • Benzeno et al. 2004. Cancer Res. 64(11):3885-91. PMID: 15172998.
- • Cyclin-dependent kinase inhibition by the KLF6 tumor suppressor protein through interaction with cyclin D1.